Monopar Therapeutics insider trading activity
Understanding Insider Activity at Monopar Therapeutics
Welcome to our dedicated page for Monopar Therapeutics (Nasdaq: MNPR) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Monopar Therapeutics's key insiders, providing a unique window into the company's internal sentiments.
How to Use This Data:
Below, you can view insider transactions that were reported to the SEC within the last 365 days.
While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.
Scroll down to view the most recent insider transactions for Monopar Therapeutics, and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.
Track insider trades for MNPR| Ticker | Time & Date | Filing | Link |
|---|---|---|---|
| MNPR | 8:17:28 PM, 10/30/2024 | Radhakrishnan Karthik(Chief Financial Officer) purchased 1550 shares of Monopar Therapeutics (MNPR) for ~$25187 | Filing |
| MNPR | 9:16:51 PM, 6/21/2024 | Cittadine Andrew(Chief Operating Officer) purchased 32508 shares of Monopar Therapeutics (MNPR) for ~$25495 | Filing |
| MNPR | 10:08:20 PM, 6/17/2024 | Cittadine Andrew(Chief Operating Officer) purchased 36000 shares of Monopar Therapeutics (MNPR) for ~$32880 | Filing |
| MNPR | 10:12:38 PM, 6/5/2024 | Cittadine Andrew(Chief Operating Officer) purchased 24000 shares of Monopar Therapeutics (MNPR) for ~$18480 | Filing |
| MNPR | 8:56:08 PM, 5/31/2024 | Cittadine Andrew(Chief Operating Officer) purchased 36000 shares of Monopar Therapeutics (MNPR) for ~$23040 | Filing |
| MNPR | 9:58:33 PM, 11/16/2022 | Cittadine Andrew(Chief Operating Officer) purchased 16053 shares of Monopar Therapeutics (MNPR) for ~$49659 | Filing |